Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Arash Kardan is active.

Publication


Featured researches published by Arash Kardan.


The Journal of Nuclear Medicine | 2009

Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET

Georges El Fakhri; Arash Kardan; Arkadiusz Sitek; Sharmila Dorbala; Nathalie Abi-Hatem; Youmna Lahoud; Alan J. Fischman; Martha Coughlan; Tsunehiro Yasuda; Marcelo F. Di Carli

82Rb cardiac PET allows the assessment of myocardial perfusion with a column generator in clinics that lack a cyclotron. There is evidence that the quantitation of myocardial blood flow (MBF) and coronary flow reserve (CFR) with dynamic 82Rb PET is feasible. The objectives of this study were to determine the accuracy and reproducibility of MBF estimates from dynamic 82Rb PET by using our methodology for generalized factor analysis (generalized factor analysis of dynamic sequences [GFADS]) and compartment analysis. Methods: Reproducibility was evaluated in 22 subjects undergoing dynamic rest and dipyridamole stress 82Rb PET studies at a 2-wk interval. The inter- and intraobserver variability of MBF quantitation with dynamic 82Rb PET was assessed with 4 repeated estimations by each of 4 observers. Accuracy was evaluated in 20 subjects undergoing dynamic rest and dipyridamole stress PET studies with 82Rb and 13N-ammonia, respectively. The left ventricular and right ventricular blood pool and left ventricular tissue time–activity curves were estimated by GFADS. MBF was estimated by fitting the blood pool and tissue time–activity curves to a 2-compartment kinetic model for 82Rb and to a 3-compartment model for 13N-ammonia. CFR was estimated as the ratio of peak MBF to baseline MBF. Results: The reproducibility of the MBF estimates in repeated 82Rb studies was very good at rest and during peak stress (R2= 0.935), as was the reproducibility of the CFR estimates (R2 = 0.841). The slope of the correlation line was very close to one for the estimation of MBF (0.986) and CFR (0.960) in repeated 82Rb studies. The intraobserver reliability was less than 3% for the estimation of MBF at rest and during peak stress as well as for the estimation of CFR. The interobserver reliabilities were 0.950 at rest and 0.975 at peak stress. The correlation between myocardial flow estimates obtained at rest and those obtained during peak stress in 82Rb and 13N-ammonia studies was very good (R2 = 0.857). Bland–Altman plots comparing CFR estimated with 82Rb and CFR estimated with 13N-ammonia revealed an underestimation of CFR with 82Rb compared with 13N-ammonia; the underestimation was within ±1.96 SD. Conclusion: MBF quantitation with GFADS and dynamic 82Rb PET demonstrated excellent reproducibility as well as intra- and interobserver reliability. The accuracy of the absolute quantitation of MBF with factor and compartment analyses and dynamic 82Rb PET was very good, compared with that achieved with 13N-ammonia, for MBF of up to 2.5 mL/g/min.


The Journal of Nuclear Medicine | 2009

Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82 Rb PET: Comparison with 13 N-Ammonia PET

Georges El Fakhri; Arash Kardan; Arkadiusz Sitek; Sharmila Dorbala; Nathalie Abi-Hatem; Youmna Lahoud; Alan J. Fischman; Martha Coughlan; Tsunehiro Yasuda; Marcelo F. Di Carli

82Rb cardiac PET allows the assessment of myocardial perfusion with a column generator in clinics that lack a cyclotron. There is evidence that the quantitation of myocardial blood flow (MBF) and coronary flow reserve (CFR) with dynamic 82Rb PET is feasible. The objectives of this study were to determine the accuracy and reproducibility of MBF estimates from dynamic 82Rb PET by using our methodology for generalized factor analysis (generalized factor analysis of dynamic sequences [GFADS]) and compartment analysis. Methods: Reproducibility was evaluated in 22 subjects undergoing dynamic rest and dipyridamole stress 82Rb PET studies at a 2-wk interval. The inter- and intraobserver variability of MBF quantitation with dynamic 82Rb PET was assessed with 4 repeated estimations by each of 4 observers. Accuracy was evaluated in 20 subjects undergoing dynamic rest and dipyridamole stress PET studies with 82Rb and 13N-ammonia, respectively. The left ventricular and right ventricular blood pool and left ventricular tissue time–activity curves were estimated by GFADS. MBF was estimated by fitting the blood pool and tissue time–activity curves to a 2-compartment kinetic model for 82Rb and to a 3-compartment model for 13N-ammonia. CFR was estimated as the ratio of peak MBF to baseline MBF. Results: The reproducibility of the MBF estimates in repeated 82Rb studies was very good at rest and during peak stress (R2= 0.935), as was the reproducibility of the CFR estimates (R2 = 0.841). The slope of the correlation line was very close to one for the estimation of MBF (0.986) and CFR (0.960) in repeated 82Rb studies. The intraobserver reliability was less than 3% for the estimation of MBF at rest and during peak stress as well as for the estimation of CFR. The interobserver reliabilities were 0.950 at rest and 0.975 at peak stress. The correlation between myocardial flow estimates obtained at rest and those obtained during peak stress in 82Rb and 13N-ammonia studies was very good (R2 = 0.857). Bland–Altman plots comparing CFR estimated with 82Rb and CFR estimated with 13N-ammonia revealed an underestimation of CFR with 82Rb compared with 13N-ammonia; the underestimation was within ±1.96 SD. Conclusion: MBF quantitation with GFADS and dynamic 82Rb PET demonstrated excellent reproducibility as well as intra- and interobserver reliability. The accuracy of the absolute quantitation of MBF with factor and compartment analyses and dynamic 82Rb PET was very good, compared with that achieved with 13N-ammonia, for MBF of up to 2.5 mL/g/min.


Coronary Artery Disease | 2007

Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy.

Calum A. MacRae; Kusai Aziz; Katherine B. Sims; Jeremy D. Schmahmann; Arash Kardan; Alexander Morss; Patrick T. Ellinor; Ahmed Tawakol; Alan J. Fischman; Henry Gewirtz


The Journal of Nuclear Medicine | 2009

A phase I study evaluating dosimetry and myocardial pharmacokinetic behavior of BFPET, a new F-18 labeled tracer for myocardial perfusion imaging

David R. Elmaleh; Arash Kardan; Sandra A. Barrow; Steven Dragotakes; John A. Correia; Steven Weise; Boyan Goumnerov; Ljiljana Kundakovic; Henry Gewirtz; Alan J. Fischman


Journal of Nuclear Cardiology | 2006

2.34: Problematic interpretation of inferior ischemia: A pilot study for investigation of underlying coronary artery disease

Arash Kardan; Henry Gewirtz; Yasushi Akutsu; Gerasimos Zervos; Alan J. Fischman; Tsunehiro Yasuda


Journal of Nuclear Cardiology | 2009

Delayed heart rate recovery after adenosine stress testing with supplemental arm exercise predicts mortality

Yasushi Akutsu; Arash Kardan; Gerasimos Zervos; Gregory S. Thomas; Henry Gewirtz; Tsunehiro Yasuda


Society of Nuclear Medicine Annual Meeting Abstracts | 2008

A phase I study to evaluate the safety and biodistribution of CardioPET as a new cardiac PET tracer: Studies in normal subjects

Arash Kardan; Timothy Shoup; Sandra A. Barrow; Steve Dragotakes; David R. Elmaleh; Alan Fischman


Journal of Nuclear Cardiology | 2006

2.33: Diagnostic accuracy of adenosine stress testing with supplemental arm exercise

Arash Kardan; Henry Gewirtz; Yasushi Akutsu; Gerasimos Zervos; G.S. Thomas; Alan J. Fischman; Tsunehiro Yasuda


Society of Nuclear Medicine Annual Meeting Abstracts | 2008

A phase I study evaluating myocardial pharmacokinetic behavior of CardioPET, a new cardiac PET tracer, in normal subjects and subjects with stable coronary artery disease

Arash Kardan; Timothy Shoup; Sandra A. Barrow; Steven Dragotakes; David R. Elmaleh; Alan Fischman


Society of Nuclear Medicine Annual Meeting Abstracts | 2008

Time course of dopamine transporter (DAT) occupancy of a long-acting formulation of dexmethylphenidate

Alan Fischman; Thomas Spencer; Joseph Biederman; Arash Kardan; E. Livni; Ali Bonab; Peter C. Meltzer

Collaboration


Dive into the Arash Kardan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan Fischman

Shriners Hospitals for Children

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Calum A. MacRae

Brigham and Women's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge